FDA Approved the New Alzheimer's Drug, Marketed as Leqembi
![US Department of Health and Human Services - Food and Drug Administration (FDA)](/sites/g/files/oketem336/files/styles/3_2_480x320/public/media/images/Depositphotos_429181528_FDA-Small.jpg.webp?itok=GyeabmTw)
Dr. Keith Vossel provides input on the new FDA-approved Alzheimer’s drug lecanemab, marketed as Leqembi, in his interview with DailyMail.com on Jan 6, 2023.
Dr. Keith Vossel provides input on the new FDA-approved Alzheimer’s drug lecanemab, marketed as Leqembi, in his interview with DailyMail.com on Jan 6, 2023.